Selected Start-Ups (12/00)
Executive SummaryIn Vivo summarizes the technologies of several recently founded companies: Roche has funneled its IP in antibiotics, antifungals and dermatology into spin-off Basilea Pharmaceutica. Building on technology invented by NASA to detect life on Mars, BioLuminate Inc. will develop a diagnostic probe to measure breast cancer indicators after initial screening has revealed a region of concern. Integrative Proteomics Inc. aims to be a dominant player in proteomics with its platform for high-throughput protein expression and purification, protein-protein interaction and 3-dimensional structure determination. invivodata inc. is offering a money-back guarantee to users of its invivosystem, a handheld method for recording, managing and analyzing real-time patient experience data during pharmaceutical clinical trials. Metazoa Systems Inc. has launched a web portal offering research management tools for life science researchers. Aventis CropScience spin-off Scynexis Chemistry & Automation Inc. will provide drug discovery chemistry services for pharmaceutical and other life sciences clients.
You may also be interested in...
A top clinical research expert says the medical device industry is lagging behind the pharmaceutical industry when it comes to engaging patients. While industry groups are pushing for more patient preference be factored in in regulatory decisions, John Lewis of patient advocacy group Heart Valve Voice says medtech companies themselves are not investing enough in this area.
CMR Surgical’s Versius robotic system is now live in the UK NHS, the company announced 20 February.
Despite seeing an 8% drop in global turnover in 2019, an upbeat Teva says the completion of its restructuring plan has positioned the company to increase its turnover through newly-launched products – including biosimilars, brands and new generics – as well as improve its profit margins through manufacturing optimization.